Côte d'Ivoire vs Guinea-Bissau: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Côte d'Ivoire
75.0%
in 2024
Guinea-Bissau
74.0%
in 2024
Côte d'Ivoire rank
115th
Guinea-Bissau rank
118th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Côte d'Ivoire
- Guinea-Bissau
How they compare
Côte d'Ivoire currently reports 75.0% against 74.0% in Guinea-Bissau, a difference of 1.0%.
The two have swapped places 4 times across 10 shared years of data; in 2015 it was Côte d'Ivoire ahead.
Côte d'Ivoire ranks 115th and Guinea-Bissau ranks 118th of 146 countries.
Across the 2 decades both report, Côte d'Ivoire averaged higher in 1 and Guinea-Bissau in 1.
Head to head by decade
| Decade | Côte d'Ivoire | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.4% | 66.4% | 12.0% | Côte d'Ivoire |
| 2020s | 71.4% | 72.6% | 1.2% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Côte d'Ivoire or Guinea-Bissau?
- Côte d'Ivoire, at 75.0% against 74.0% in Guinea-Bissau as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Côte d'Ivoire and Guinea-Bissau?
- 1.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Guinea-Bissau?
- 10 years are reported by both, from 2015 to 2024.
- How do Côte d'Ivoire and Guinea-Bissau rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Côte d'Ivoire ranks 115th and Guinea-Bissau ranks 118th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.